Ludwig Enterprises (LUDG) Cash from Financing Activities (2022 - 2026)
Ludwig Enterprises (LUDG) posted Cash from Financing Activities of $170982.0 for Q1 2026, up 1590.05% on a QoQ basis from $10117.0 in Q4 2025, and up 72.03% year-over-year from $99392.0 in Q1 2025.
Ludwig Enterprises (LUDG) Cash from Financing Activities (2022 - 2026) Analysis & Trends
Ludwig Enterprises' Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $170982.0 for Q1 2026.
- Quarterly Cash from Financing Activities rose 72.03% year-over-year to $170982.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $718857.0 (up 125.98% YoY) and the FY2025 annual result came in at $647267.0, up 15.85% from the prior year.
- Cash from Financing Activities was $170982.0 for Q1 2026 at Ludwig Enterprises, up from $10117.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $755000.0 in Q4 2022 and bottomed at $10117.0 in Q4 2025.
- A 5-year average of $215632.5 and a median of $99708.0 in 2024 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 532.66% in 2025, while the deepest fall reached 89.85% in 2025.
- Ludwig Enterprises' Cash from Financing Activities stood at $755000.0 in 2022, then tumbled by 77.48% to $170000.0 in 2023, then plunged by 41.35% to $99708.0 in 2024, then plunged by 89.85% to $10117.0 in 2025, then soared by 1590.05% to $170982.0 in 2026.
- Business Quant data shows LUDG's Cash from Financing Activities at $170982.0 in Q1 2026, $10117.0 in Q4 2025, and $537758.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | -451.20 Mn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 21.00 Mn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | -25.00 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | -26.93 Mn |
| 10 | Ludwig Enterprises | 3.27 Mn | 3.27 Mn | - | 170,982.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170,982.00 |
| Mar 31, 2026 | 170,982.00 |
| Dec 31, 2025 | 10,117.00 |
| Dec 31, 2025 | 10,117.00 |
| Jun 30, 2025 | 537,758.00 |
| Jun 30, 2025 | 537,758.00 |
| Mar 31, 2025 | 99,392.00 |
| Mar 31, 2025 | 99,392.00 |
| Dec 31, 2024 | 99,708.00 |
| Dec 31, 2024 | 99,708.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 85,000.00 |
| Jun 30, 2024 | 85,000.00 |
| Mar 31, 2024 | 340,000.00 |
| Mar 31, 2024 | 340,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Mar 31, 2023 | 70,000.00 |
| Mar 31, 2023 | 70,000.00 |